SubscribeGet APP

With approvals Sputnik V delivery in India possible by end of 2020: Kirill Dmitriev, CEO, RDIF

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund has tied up with India's Dr Reddy’s Laboratories to conduct the clinical trials and distribution of Sputnik V vaccine in India. ET’s Divya Rajagopal caught up with CEO RDIF, Kirill Dmitriev to understand when the vaccine will be available in India. Watch
Share this Video


This article has been saved